Elaborating on the effective methods being followed for treating COVID-19 across the globe, Shashikanth Manikappa, a specialist cardiac anaesthetist working at Monash Health in Melbourne, Australia, has strongly advised what he termed Quadruple Therapy involving four medicines — Ivermectin, Doxycycline, Zinc and Vitamin D3 — as a preventive as well as treating method.
Addressing a media conference in Kalaburagi on Monday, the senior doctor said that the use of Ivermectin would be more effective than that of Hydroxychloroquine which was widely being used worldwide, right from the outbreak of the pandemic.
Referring to a pre-official release of a randomised controlled trial using Ivermectin in three doses in primary contacts of COVID-19, Dr. Manikappa said that 93 % of primary contacts who received Ivermectin did not develop any symptoms and 58 % of primary contacts who did not receive Ivermectin did progress to have symptoms of the pandemic.
“Quadruple Therapy includes Ivermectin 12 mg one dose, Doxycycline 100 mg once a day for four days, Zinc 50 mg once a day for four days and Vitamin D3 once a week. Ivermectin, Doxycycline and Zinc are to be repeated every 14 days and Vitamin D3 every week with blood levels monitored. The synergistic effect of these medicine acts to prevent viral multiplication and also stop the virus from entering human cells. Thomas Borody, an Australian gastroenterologist who is known for curing peptic ulcers with triple antibiotic therapy, has revealed that one block in South America that received Ivermectin combination prophylaxis did not contract coronavirus infection while others did,” he said.
On the side effects, Dr. Manikappa said that Ivermectin was being used in 3.7 billion people for intestinal parasites and was found to be safe. “These are not new medicine. They are already in use for treating different ailments and are found to be safe. They can be prescribed by any doctor to control the pandemic,” he said.
Asked about the statutory guidelines for the use of these medicine, Dr. Manikappa said that the Indian Council of Medical Research (ICMR) had, though late, come up with new guidelines recommending Ivermectin.
District Kannada Vaidya Sahitya Parishat president S.S. Gubb and joint secretary Shashishekhar Reddy were present.